Topical diclofenac usage among Medicare beneficiaries rose 1621% (2015-2019) independent of marketing, potentially reflecting therapeutic substitution driven by national efforts to reduce opioid prescribing.
Kanaka D. Shetty, MD, MS
Advertisement
Articles by Kanaka D. Shetty, MD, MS
Hospitals reported widespread adoption of quality improvement (QI) changes to improve on CMS quality measures, and QI adoption was associated with improved performance on quality measures.
Advertisement
Latest Updated Articles
- Actions to Improve Quality: Results From a National Hospital Survey
December 8th 2021
Rapid Increase in Topical Diclofenac Use for Chronic Pain, 2011-2020October 27th 2026
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Acoramidis Linked to Fewer Hospitalizations Than Tafamidis in ATTR-CM
3
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
4
EEOC Reportedly Plans to Narrow Pregnancy Accommodation Rules
5